United States v. Mimms

43 F.3d 217, 1995 WL 15101
CourtCourt of Appeals for the Fifth Circuit
DecidedFebruary 1, 1995
DocketNo. 94-40247
StatusPublished
Cited by32 cases

This text of 43 F.3d 217 (United States v. Mimms) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Mimms, 43 F.3d 217, 1995 WL 15101 (5th Cir. 1995).

Opinion

PER CURIAM:

William Earl Mimms (Mimms) appeals the amount that the district court reduced his sentence pursuant to his 28 U.S.C. § 2255 motion. Finding the calculation of phenylac-etone (P2P) clearly erroneous, we vacate and remand.

I. PROCEDURAL HISTORY

William Earl Mimms pleaded guilty to conspiracy to manufacture and distribute amphetamine in violation of 21 U.S.C. § 846. In 1991, pursuant to the sentencing guidelines, the district court properly sentenced him to 151 months imprisonment. Mimms apparently did not take a direct appeal. In 1993, Mimms filed this action under 28 U.S.C. § 2255, seeking to have his sentence reduced by applying an amendment to U.S.S.G. § 2Dl.l(c), which adopted a new method for calculating the quantity of drugs to be used in determining the offense level and guideline range. The district court held a hearing at which two expert chemists testified. After making new findings regarding the quantity of drugs involved, the court reduced Mimms’ sentence from 151 months to 115 months.

II. ANALYSIS

A. Treating the claim under 18 U.S.C. § 3582(c)(2).

In the court below, Mimms, proceeding pro se and in forma pauperis, filed this action to reduce his sentence under § 2255. “Relief under 28 U.S.C.A. § 2255 is reserved for transgressions of constitutional rights and for a narrow range of injuries that could not have been raised on direct appeal and would, if condoned, result in a complete miscarriage of justice.” United States v. Vaughn, 955 F.2d 367, 368 (5th Cir.1992). Even if a defendant alleges a constitutional error, he may not raise an issue for the first time on collateral review without showing both cause for his procedural default and actual prejudice resulting from the error. United States v. Shaid, 937 F.2d 228, 232 (5th Cir.1991) (en banc), cert. denied, — U.S. -, 112 S.Ct. 978, 117 L.Ed.2d 141 (1992).

Mimms raises this issue for the first time on collateral review. However, because the amendment upon which Mimms relies (§ 2Dl.l(e)) did not become effective until November 1, 1993, Mimms could not have raised this claim on a direct appeal. Nevertheless, we have held that this precise claim is not cognizable in a § 2255 action because the sentence was valid at the time of imposition, and thus, “does not give rise to a eom: píete miscarriage of justice.” United States v. Towe, 26 F.3d 614, 616 (5th Cir.1994).

However, Mimms could have brought this claim pursuant to 18 U.S.C. § 3582(e)(2). Towe, 26 F.3d at 616; United States v. Segler, 37 F.3d 1131, 1134 (5th Cir.1994). Section 3582(e)(2) allows a court to reduce a defendant’s sentence if the term of imprisonment was based on a guideline range that subsequently has been lowered and such a reduction would be consistent with the applicable policy statements in the guidelines. Towe, 26 F.3d at 616. The applicable policy statement provides that the amendment at issue may be applied retroactively. U.S.S.G. 1B1.10, p.s. Under § 3582(c)(2), the district court has the discretion whether to reduce the sentence. United States v. Shaw, 30 F.3d 26, 28-29 (5th Cir.1994).

Here, in response to the § 2255 motion, the government did not argue that the claim was not cognizable, but rather acknowledged that the amendment should be applied retroactively and moved for an evidentiary hearing to determine the amount of drugs to be used in the new sentence calculation. The district court, after an evidentiary hearing, determined that Mimms was entitled to a reduction under the amended § 2Dl.l(e). Because the government had no objection1 and a hearing was held to determine the reduction pursuant to § 2Dl.l(c), we will not put form over substance. The trial court has already conducted the hearing that would be allowed under § 3582(e)(2). For these rea[220]*220sons and in the interest of judicial economy, we treat this action as a proceeding under § 3582(c)(2).

B. Whether the district court’s finding that Exhibit 2B contained 20% phenyl-acetone was clearly erroneous.

Mimms argues that the district court committed clear error by misinterpreting the expert’s testimony and by miscalculating the quantity of drugs to be used to determine his new offense level and new guideline sentence. Apparently, we have not expressly stated the standard of review for findings of fact made in a proceeding under § 3582(c)(2). We review the district court’s factual findings in a § 2255 proceeding for clear error. United States v. Gipson, 985 F.2d 212, 214 (5th Cir.1993). Likewise, on direct appeal, we review findings of fact made in regard to sentencing for clear error. United States v. Humphrey, 7 F.3d 1186, 1189 (5th Cir.1993) (citing 18 U.S.C. § 3742(e)). Accordingly, we now hold that findings of fact made during a § 3582(c)(2) proceeding are reviewed under the clearly erroneous standard. A finding of fact will be set aside as clearly erroneous only if, although there is evidence to support it, we are left with the definite and firm conviction that a mistake has been committed. United States v. Fitzhugh, 984 F.2d 143, 146 n. 12 (5th Cir.), cert. denied, — U.S. -, 114 S.Ct. 259, 126 L.Ed.2d 211 (1993).

Mimms’ original sentence was based on the entire quantities of the substances found to have a detectable amount of controlled substance in accordance with the version of § 2Dl.l(c) in effect in 1991. In 1993, § 2Dl.l(c) was amended to provide that:

[mjixture or substance does not include materials that must be separated from the controlled substance before the controlled substance can be used. Examples of such materials include ... waste water from an illicit laboratory used to manufacture a controlled substance. If such material cannot readily be separated from the mixture or substance that appropriately is counted in the Drug Quantity Table, the court may use any reasonable method to approximate the weight of the mixture or substance to be counted.

§ 2Dl.l(e), comment, (n.l); U.S.S.G.App. C, amend. 484.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Exdonovan Peak
361 F. App'x 619 (Fifth Circuit, 2010)
United States v. Davenport
200 F. App'x 378 (Fifth Circuit, 2006)
United States v. Privette
129 F. App'x 897 (Fifth Circuit, 2005)
United States v. Stricklin
290 F.3d 748 (Fifth Circuit, 2002)
United States v. Guerrieri
22 F. App'x 605 (Sixth Circuit, 2001)
United States v. Willis
273 F.3d 592 (Fifth Circuit, 2001)
United States v. Manthei
Fifth Circuit, 2001
United States v. Hinton
3 F. App'x 424 (Sixth Circuit, 2001)
United States v. Charles Ray Polk
118 F.3d 286 (Fifth Circuit, 1997)
United States v. Polk
Fifth Circuit, 1997
Harrelson v. United States
967 F. Supp. 909 (W.D. Texas, 1997)
United States v. Dozie McKee Melvin III
107 F.3d 872 (Sixth Circuit, 1997)
United States v. Robert Rolando Guerra
94 F.3d 989 (Fifth Circuit, 1996)
United States v. Guerra
Fifth Circuit, 1996
United States v. Swisher
Fifth Circuit, 1996
United States v. Michael T. May
81 F.3d 161 (Sixth Circuit, 1996)

Cite This Page — Counsel Stack

Bluebook (online)
43 F.3d 217, 1995 WL 15101, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-mimms-ca5-1995.